We are live on ! Find out more
MDXG icon

MiMedx Group

177 hedge funds and large institutions have $337M invested in MiMedx Group in 2023 Q2 according to their latest regulatory filings, with 31 funds opening new positions, 57 increasing their positions, 41 reducing their positions, and 17 closing their positions.

New
Increased
Maintained
Reduced
Closed

82% more first-time investments, than exits

New positions opened: 31 | Existing positions closed: 17

50% more funds holding in top 10

Funds holding in top 10: 23 (+1)

39% more repeat investments, than reductions

Existing positions increased: 57 | Existing positions reduced: 41

31% more capital invested

Capital invested by funds: $257M → $337M (+$80M)

14% more call options, than puts

Call options by funds: $747K | Put options by funds: $658K

9% more funds holding

Funds holding: 163177 (+14)

16.1% less ownership

Funds ownership: 60.16%44.06% (-16%)

Holders
177
Holders Change
+14
Holders Change %
+8.59%
% of All Funds
2.78%
Holding in Top 10
3
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+50%
% of All Funds
0.05%
New
31
Increased
57
Reduced
41
Closed
17
Calls
$747K
Puts
$658K
Net Calls
+$89K
Net Calls Change
+$48K
Name Holding Trade Value Shares
Change
Change in
Stake
BlackRock
1
BlackRock
New York
$53.7M +$820K +160,933 +2%
Vanguard Group
2
Vanguard Group
Pennsylvania
$40.9M +$443K +86,890 +1%
PCMI
3
Paradigm Capital Management Inc
New York
$23M +$153K +29,998 +0.9%
State Street
4
State Street
Massachusetts
$22.2M -$1.96M -385,270 -10%
Geode Capital Management
5
Geode Capital Management
Massachusetts
$15.4M +$677K +132,740 +6%
RB
6
Richmond Brothers
Michigan
$10.5M -$860K -168,627 -10%
Millennium Management
7
Millennium Management
New York
$9.43M +$7M +1,373,237 +2,553%
Morgan Stanley
8
Morgan Stanley
New York
$8.32M +$4.13M +810,314 +181%
CC
9
Cannell Capital
Wyoming
$7.27M +$3.55M +696,594 +173%
Northern Trust
10
Northern Trust
Illinois
$6.76M +$101K +19,795 +2%
Charles Schwab
11
Charles Schwab
California
$6.55M +$292K +57,265 +6%
D.E. Shaw & Co
12
D.E. Shaw & Co
New York
$6.44M +$2.26M +443,200 +83%
Renaissance Technologies
13
Renaissance Technologies
New York
$5.95M +$106K +20,800 +2%
RA
14
Royce & Associates
New York
$5.79M +$172K +33,700 +4%
Federated Hermes
15
Federated Hermes
Pennsylvania
$5.59M -$545K -106,958 -11%
KWM
16
Kanen Wealth Management
Florida
$5.52M +$4.26M +834,912 New
Prudential Financial
17
Prudential Financial
New Jersey
$5.44M +$157K +30,800 +4%
DSCM
18
Divisadero Street Capital Management
Florida
$5.29M +$4.08M +800,000 New
PI
19
Putnam Investments
Massachusetts
$3.72M +$2.87M +563,045 New
Bank of America
20
Bank of America
North Carolina
$3.64M -$263K -51,632 -9%
EI
21
EAM Investors
California
$3.63M +$2.8M +549,333 New
AW
22
Apricus Wealth
South Carolina
$3.42M
Two Sigma Investments
23
Two Sigma Investments
New York
$3.2M +$2.22M +435,984 +920%
Goldman Sachs
24
Goldman Sachs
New York
$3.13M +$752K +147,549 +45%
Invesco
25
Invesco
Georgia
$3.1M +$2.19M +429,442 +1,067%

MDXG Hedge Fund Activity: Q2 2023 in Review

177 of the 6,370 institutional investors tracked by Wall St. Rank reported a position in MiMedx Group (MDXG) for Q2 2023, worth a combined $337M — up 31% from $257M a quarter earlier.

Buyers outnumbered sellers: 31 funds opened new MDXG positions and 17 closed out — a net gain of 14 holders — while 57 added to existing stakes and 41 trimmed.

The largest buyer was Millennium Management, adding an estimated $7M. The largest seller was Essex Woodlands Management, exiting entirely with an estimated $79.8M sold.

  • 177 institutional investors held MiMedx Group (MDXG) as of Q2 2023, up from 163 in Q1 2023.
  • Funds reported $337M of MiMedx Group stock for Q2 2023, up 31% quarter-over-quarter.
  • 31 funds opened new MiMedx Group positions in Q2 2023 and 17 closed out, a net change of +14 holders.
  • The largest MiMedx Group buyer in Q2 2023 was Millennium Management, an estimated $7M added.
  • The largest MiMedx Group seller in Q2 2023 was Essex Woodlands Management, an estimated $79.8M sold.

Based on aggregated 13F filings for Q2 2023.